Benzinga··Lekha GuptaSynopsys Shares Slide on Weak Guidance Despite Earnings Beat
Synopsys beat Q1 earnings but stock fell 3.44% on weak forward guidance, flat IP revenue, and China weakness concerns.
SNPSstock declineSynopsys
price target reduction
2 articlesBenzinga··Lekha Gupta
The Motley Fool··Scott LevineNuScale Power Faces Significant Valuation Cuts From Major Analysts
Barclays slashed NuScale Power's price target 67% to $15, joining Goldman Sachs in downgrading the small modular reactor developer amid concerns about commercialization viability.
SMROKLOBCSQ4 2025 earningsNuScale Power